Positron Corporation (POSC)
-OTC Markets 0.01 0.00(0.00%) 2:32PM EDT
| Prev Close: | 0.01 |
|---|
| Open: | 0.01 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 2.41 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.01 - 0.01 |
|---|
| 52wk Range: | 0.01 - 0.02 |
|---|
| Volume: | 37,300 |
|---|
| Avg Vol (3m): | 538,836 |
|---|
| Market Cap: | 10.46M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.00 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- POSITRON CORP FinancialsEDGAR Online Financials(Thu 1:04PM EDT)
- POSITRON CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 17)
- Positron And Biologics Modular Enter Into Co-Marketing AgreementPR Newswire(Fri, May 3)
- Positron Introduces Next Generation PosiRx Pharmacy Automation SystemsPR Newswire(Wed, May 1)
- POSITRON CORP Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 15)
- POSITRON CORP Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Wed, Jan 30)
- POSITRON CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Nov 15)
- POSITRON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,EDGAR Online(Thu, Nov 1)
- POSITRON CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Aug 14)
- POSITRON CORP FinancialsEDGAR Online Financials(Fri, May 25)
- POSITRON CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 21)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 4.46 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Positron Corporation, a nuclear medicine healthcare company, provides positron emission tomography (PET) molecular imaging systems, automated radiopharmaceutical systems, radiopharmaceuticals, radioisotopes, and clinical and support services.
View More 
0.08%